Research
Excludes commercial-in-confidence projects.
Novel approaches to control mast cell function in allergic inflammation., NHMRC - Project Grant, 01/01/2017 - 31/12/2020
Aberrant signalling in leukaemia, NHMRC - Program Grant, 01/01/2015 - 31/12/2019
Cancer Discovery Accelerator, Australian Cancer Research Foundation, 01/06/2016 - 31/07/2018
Defining the role of VEGF and vascular formation in craniofacial development, NHMRC - Project Grant, 01/01/2014 - 31/12/2017
Cancer Discovery Accelerator, Cancer Council SA - Beat Cancer, 08/06/2016 - 08/06/2017
Novel approaches to control mast cell function, Channel 7 Children's Research Foundation of SA, 01/01/2016 - 31/12/2016
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2023 |
1
|
2015 |
|
Year | Output |
---|---|
2024 |
Open access
|
2024 |
Open access
1
|
2024 |
Open access
49
|
2023 |
Open access
4
20
|
2023 |
2
4
|
2023 |
Open access
6
3
1
|
2023 |
Open access
2
1
|
2022 |
Open access
247
233
1941
|
2022 |
Open access
5
5
|
2022 |
Open access
13
13
12
|
2022 |
Open access
14
11
6
|
2022 |
Open access
3
2
2
|
2021 |
Open access
24
22
6
|
2021 |
5
4
3
|
2021 |
Open access
3
1
3
|
2020 |
51
49
|
2020 |
Open access
1
1
|
2020 |
9
7
6
|
2019 |
Open access
38
40
12
|
2019 |
Open access
20
20
|
2018 |
Open access
30
28
|
2018 |
Open access
20
20
|
2018 |
Open access
33
27
14
|
2018 |
8
8
|
2018 |
Open access
39
38
3
|
2018 |
Open access
19
19
2
|
2017 |
Open access
77
73
11
|
2017 |
1
1
2
|
2017 |
Open access
16
15
|
2017 |
Open access
73
69
85
|
2017 |
Open access
26
25
1
|
2016 |
Open access
40
36
|
2016 |
Open access
32
32
|
2016 |
Open access
36
29
|
2016 |
Open access
25
24
|
2016 |
41
37
|
2016 |
Open access
36
29
|
2016 |
Open access
50
49
1
|
2016 |
Open access
5
5
|
2016 |
Open access
23
24
|
2015 |
64
57
1
|
2015 |
97
96
|
2015 |
13
12
2
|
2015 |
Open access
30
23
25
|
2015 |
Open access
51
48
|
2015 |
Open access
50
49
|
2015 |
Open access
16
15
4
|
2015 |
Open access
32
27
3
|
2015 |
Open access
37
35
1
|
2014 |
Open access
47
41
|
2014 |
Open access
48
110
|
2014 |
Open access
85
80
|
2014 |
Open access
16
16
|
2014 |
Open access
91
91
1
|
2014 |
Open access
97
87
33
|
2013 |
Open access
81
73
|
2013 |
Open access
170
155
|
2012 |
195
181
|
2012 |
Open access
91
86
|
2012 |
Open access
60
57
|
2012 |
Open access
35
30
|
2010 |
Open access
127
116
|
2010 |
Open access
60
55
|
2009 |
Open access
33
30
|
2009 |
Open access
38
36
|
2009 |
Open access
448
405
|
2008 |
Open access
108
105
|
2008 |
Open access
260
242
|
Research
Details | Registry | Status |
---|---|---|
Markers of endothelial progenitor cells and uses thereof Bonder, Claudine Sharon; Lopez, Angel Fransciso; Talbo, Gert Hoy |
AU | Granted |
Markers of endothelial progenitor cells and uses thereof Bonder, Claudine Sharon; López, Ángel Fransciso; Talbo, Gert Hoy |
EP | Filed |
Markers of endothelial progenitor cells and uses thereof Bonder, Claudine Sharon; Lopez, Angel Fransciso; Talbo, Gert Hoy |
US | Filed |
Markers of endothelial progenitor cells and uses thereof Bonder, Claudine Sharon; Lopez, Angel Fransciso; Talbo, Gert Hoy |
WO | Filed |
Bonder, Claudine Sharon; Lopez, Angel Fransciso |
WO | Filed |
Lopez, Angel; Schwarz, Quenten |
Australia | Filed |
Methods for treating inflammatory skin conditions Owczarek, Catherine; Lopez, Angel; Yip, Kwok Ho; Tumes, Damon |
WO | Granted |
Methods for treating or preventing acute respiratory distress syndrome Owczarek, Catherine; Campbell, Ian; Krstevski, Karolina; Bozinovski, Steven; Lopez, Angel; Tumes, Damon |
World | Granted |
Modulators of 14-3-3 functionality and uses thereof Woodcock, Joanna; Lopez, Angel; Pitson, Stuart M; Samuel, Michael S; Coolen, Carl |
United States | Filed |
Modulators of 14-3-3 functionality and uses thereof Woodcock, Joanna; Lopez, Angel; Pitson, Stuart; Samuel, Michael; Coolen, Carl |
WO | Filed |
Novel cancer treatment involving modulation of il-3 activity Lopez, Angel F; Bonder, Claudine S; Thompson, Emma |
WO | Filed |
Schwarz, Quenten; Lopez, Angel |
Australia | Filed |
External engagement & recognition
Organisation | Country |
---|---|
A-Star, Institute of Molecular and Cell Biology | SINGAPORE |
Australian National University | AUSTRALIA |
BreastScreen SA | AUSTRALIA |
Case Western Reserve University | UNITED STATES |
Children's Cancer Institute Australia | AUSTRALIA |
City University of New York | UNITED STATES |
City University Of New York, Queens College | UNITED STATES |
Cleveland Clinic Foundation | UNITED STATES |
CSL Limited | AUSTRALIA |
CSL LTD | AUSTRALIA |
CSL Pharmaceutical Group | AUSTRALIA |
Deakin University | AUSTRALIA |
Drexel University | UNITED STATES |
Envoi Specialist Pathologists | AUSTRALIA |
Flinders University | AUSTRALIA |
Genentech, Inc. | UNITED STATES |
Harry Perkins Institute of Medical Research | AUSTRALIA |
Hudson Institute of Medical Research | AUSTRALIA |
IBM Australia | AUSTRALIA |
Institute of Medical and Veterinary Science | AUSTRALIA |
La Trobe University | AUSTRALIA |
Leland Stanford Junior University (Stanford) | UNITED STATES |
Malaghan Institute of Medical Research | NEW ZEALAND |
McGill University | CANADA |
Medical University of Graz | AUSTRIA |
Mental Health Research Institute of Victoria | AUSTRALIA |
Monash University | AUSTRALIA |
Murdoch Childrens Research Institute | AUSTRALIA |
Nagoya University | JAPAN |
National Institutes of Health | UNITED STATES |
Osnabrueck University | GERMANY |
Peter MacCallum Cancer Centre | AUSTRALIA |
Prince Henry's Institute of Medical Research | AUSTRALIA |
Princess Alexandra Hospital | AUSTRALIA |
QIMR Berghofer Medical Research Institute | AUSTRALIA |
Queensland Institute of Medical Research | AUSTRALIA |
RMIT University | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Royal Children's Hospital | UNITED KINGDOM |
Royal College of Surgeons in Ireland | IRELAND |
Royal Melbourne Hospital | AUSTRALIA |
Royal Victorian Eye and Ear Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
St Vincents Hospital | UNITED STATES |
St. Vincent's Institute of Medical Research | AUSTRALIA |
Stanford University | UNITED STATES |
Texas A and M University | UNITED STATES |
The Kinghorn Cancer Centre | AUSTRALIA |
The Queen Elizabeth Hospital | AUSTRALIA |
UCSF School of Medicine | UNITED STATES |
University College London | UNITED KINGDOM |
University Health Network | CANADA |
University of Adelaide | AUSTRALIA |
University of British Columbia | CANADA |
University of California | UNITED STATES |
University of Frankfurt | GERMANY |
University of Melbourne | AUSTRALIA |
University of Montreal | CANADA |
University of New South Wales | AUSTRALIA |
University of Newcastle | AUSTRALIA |
University of Queensland | AUSTRALIA |
University of Rome Tor Vergata | ITALY |
University of Sherbrooke | CANADA |
University of South Australia | AUSTRALIA |
University of Southern California | UNITED STATES |
University of Sydney | AUSTRALIA |
University of Western Australia | AUSTRALIA |
Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
Westmead Hospital | AUSTRALIA |
Women's and Children's Hospital | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
Officer of the Order of Australia (AO)Order of Australia |
2017 |
Project GrantNational Health and Medical Research Council (NHMRC) |
2016 |
FellowAustralian Academy of Health and Medical Science |
2015 |
FellowAustralian Academy of Science |
2014 |
Research Excellence Award, Top Ranked ApplicationNational Health and Medical Research Council (NHMRC) |
2013 |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Deciphering how airway epithelial programming and inflammation cause chronic allergic airways disease | Current |
Interleukin-3 (IL-3) promotes blood vessel development in breast cancer | Current |
Revealing the role of ICAM1 in breast cancer progression | Current |
Understanding the role of 14-3-3 proteins in lung cancer initiation, progression and metastasis. | Current |